What are the most cited papers from Crolll (Germany)?
The most cited paper from Crolll (Germany) is "Second-line therapy with nivolumab plus ipilimumab for older patients with oesophageal squamous cell cancer (RAMONA): a multicentre, open-label phase 2 trial" (Matthias P A Ebert et al., 2022), with 31 citations. Next come "An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial" (5) and "Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study" (4).
Showing 8 of 8 papers.Every paper is listed.
Most cited papers, sortable by citations and release date
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or
Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation;
retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown.
How the lists are chosen.